Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Kailera Therapeutics has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China ...

In patients with type 2 diabetes, GLP-1 receptor agonists and SGLT2 inhibitors have similar kidney ... Please see the original reference for a full list of authors’ disclosures.

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...

We recently compiled a list of 10 Worst Falling Stocks To Buy Now. In this article, we will look at where Scholar Rock ...